Share Email Print
cover

Proceedings Paper

Comparison of laser- and RF-based interstitial coagulation systems for the treatment of liver tumors
Author(s): Arjan A. de Jager; Bart N.G.M. van Trier; Liesbeth M. Veenendaal; Richard van Hillegersberg; Rudolf M. Verdaasdonk
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Hepatocellular carcinoma (HCC) is one of the most common cancers in the world. Surgical treatments, including hepatic resection and liver transplantation are considered as the most effective treatment of HCC. However, less than 20% of HCC patients can be treated surgically because of: multi-focal diseases, proximity of tumor to key vascular or biliary structures and inadequate functional hepatic reserve related coexistent cirrhosis. In this unfortunate groups of patients various palliative treatments modalities are being performed to extend the time of survival and quality of life. These techniques include trans-catheter arterial chemoembolization (TACE), percutaneous ethanol injection (PEI) and Interstitial Thermal Therapy: laser-induced interstitial thermotherapy (LITT) and radio-frequency ablation (RFA).

Paper Details

Date Published: 14 April 2005
PDF: 12 pages
Proc. SPIE 5698, Thermal Treatment of Tissue: Energy Delivery and Assessment III, (14 April 2005); doi: 10.1117/12.589175
Show Author Affiliations
Arjan A. de Jager, Univ. Medical Ctr. Utrecht (Netherlands)
Bart N.G.M. van Trier, Univ. Medical Ctr. Utrecht (Netherlands)
Liesbeth M. Veenendaal, Univ. Medical Ctr. Utrecht (Netherlands)
Richard van Hillegersberg, Univ. Medical Ctr. Utrecht (Netherlands)
Rudolf M. Verdaasdonk, Univ. Medical Ctr. Utrecht (Netherlands)


Published in SPIE Proceedings Vol. 5698:
Thermal Treatment of Tissue: Energy Delivery and Assessment III
Thomas P. Ryan, Editor(s)

© SPIE. Terms of Use
Back to Top